Search

everythinglearnresearchcommunity

for

Search:↓

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

4-(4-Phenoxybenzoyl)benzoic acid derivatives can both increase and decrease certain types of reactive oxygen species, and may be relevant to hair loss.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

Finasteride exposure harms tadpole reproduction and hormone balance.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Reduced androgens linked to kinky hair disorder and hair loss; 5a-reductase inhibitors may help.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

Finasteride poorly inhibits type 1 5AR, affecting its effectiveness.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

Finasteride effectively blocks rat enzymes, but with varying methods and strength.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Ketoconazole increases finasteride's effectiveness and lifespan in the body.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

New compounds may help treat prostate cancer by reducing cell growth.